arrow
R

Robert J. Konrad

Eli Lilly and Company
H指数:51
被引数:8,987

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Unraveling the physiological impact of ANGPTL8 loss-of-function variants in humans

解析人类ANGPTL8功能缺失变异的生理影响

2026-04-290
OA
Angiopoietin-like 3 monomers are abundant in human plasma but are unable to inhibit endothelial lipase

血管生成素样蛋白3单体在人类血浆中含量丰富,但无法抑制内皮脂酶

2025-12-080
OA
Affinity Capture Elution Coupled with Cell-based Cyclic Adenosine Monophosphate Assay as a Platform Method for Detection of Neutralizing Antibodies to Incretin Molecules

亲和捕获-洗脱结合细胞基环腺苷酸测定法,作为一种检测抑制素分子中和抗体的平台方法

2025-10-130
PRE
Associations of ANGPTL Proteins and Complexes with Progression of Coronary Artery Calcification and Coronary Events

ANGPTL蛋白及其复合物与冠状动脉钙化进展及冠状动脉事件的关系

2025-08-130
PRE
Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids

接受雷特拉曲肽治疗后,循环中ANGPTL3/8浓度的降低与血清脂质的减少相平行。

2025-07-290
OAAI
ANGPTL3/8 is an atypical unfoldase that regulates intravascular lipolysis by catalyzing unfolding of lipoprotein lipase

ANGPTL3/8是一种非典型的展开酶,通过催化脂蛋白脂肪酶的展开来调节血管内脂解作用。

2025-03-201
OA
Carboxyl- terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity

APOA5中的羧基末端序列对于抑制ANGPTL3/8活性很重要

2024-04-163
PRE
Hypertriglyceridemia in Apoa5-'- mice results from reduced amounts of lipoprotein lipase in the capillary lumen
2023-12-018
OAAI